Al-Razi Medical Co.
9572.SRSAUHealthcare● Active
$29.22
+$0.90(+3.18%)
Market Cap$44414400
P/E Ratio—
52W High$45.7
52W Low$25.1
Al-Razi Medical Co. (9572.SR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 9572.SR · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $1.07M | $0.53M | $0.69M | $2.01M | $2.16M |
| Depreciation & Amort. | $3.61M | $1.50M | $3.69M | $2.68M | $2.00M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Change in Working Capital | $0.15M | $0.37M | $0.62M | ($3.22M) | ($6.55M) |
| Net Cash from Operations | $5.82M | $4.96M | $5.78M | $2.03M | ($1.71M) |
| Investing Activities | |||||
| Capital Expenditure | ($1.98M) | ($3.87M) | ($4.78M) | ($2.92M) | ($1.15M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($1.97M) | ($3.87M) | ($5.04M) | ($2.92M) | ($1.15M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | ($2.41M) | ($1.89M) | $0.00M |
| Debt Issued / Repaid | ($1.94M) | $2.00M | $0.72M | ($0.75M) | ($2.02M) |
| Net Cash from Financing | ($4.31M) | ($1.02M) | ($1.29M) | ($5.43M) | $10.33M |
| Free Cash Flow | |||||
| Free Cash Flow | $3.84M | $1.09M | $1.00M | ($0.89M) | ($2.87M) |
| FCF Margin %(computed) | 5.17% | 1.78% | 1.63% | -1.70% | -6.34% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · M
Explore more Al-Razi Medical Co. data
About Al-Razi Medical Co. (9572.SR) Cash Flow Statement
Al-Razi Medical Co. generated operating cash flow of $0.01B and free cash flow of $0.00B for 2025 — a FCF margin of 5.17%. Capital expenditure was ($0.00B).
Frequently asked questions
9572.SR · 4 questionsAl-Razi Medical Co. generated free cash flow of $0.00B for 2025, up 252.6% year-over-year.
9572.SR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15